Rev. Bras. Reumatol. vol.52 número5 en v52n5a02

Methods: Anti-cyclic citrullinated peptide antibodies was tested for with an enzyme linked immunoabsorbent assay (ELISA) in serum samples of patients from the Hospital de Clínicas

Most patients with acute uveitis seek emergency services, where uveitis is classi fi ed according to the International Uveitis Study Group classi fi cation (location, clinical

The Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology has developed th e consensus published in this journal 10 aimed at summarizing the recom- mendations

ABSTRACT: The paper entitled Ahlin E, Elshafei A, Nur M, El Sai SH, Johan R, Elghazali G. Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients

The article “Adalimumab in rheumatoid arthritis treatments: a systematic review and meta-analysis of randomized clinical trials” (Rev Bras Reumatol 2013;53(5):419-430) was

The article “Psychiatric comorbidities in patients with systemic lupus erythematosus: a systematic review of the last 10 years” (Rev Bras Reumatol 2013;53(5):431-437) was

Anti-cyclic citrullinated peptide (anti-CCP), anti-mutated citrullinated vimentin (anti-MCV) and IgA-rheumatoid factor (RF) were deter- mined by ELISA and IgM-RF by latex

Anticyclic citrullinated peptide antibody and rheumatoid factor in South Tunisian patients with rheumatoid arthritis: association with disease activity and severity. Farid SSh, Azizi